Scarica l'app Stockscreener
73.34
0.07%
0.05
Dopo l'orario di chiusura:
75.88
2.54
+3.46%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché HALO Giù?
Forum
Previsione
Halozyme Therapeutics Inc Borsa (HALO) Ultime notizie
Can volume confirm reversal in Halozyme Therapeutics Inc.Chart Signals & Precise Entry and Exit Recommendations - newser.com
Key metrics from Halozyme Therapeutics Inc.’s quarterly dataJuly 2025 Short Interest & Risk Controlled Daily Plans - newser.com
Halozyme: Royalty Harvest Now, Post-2027 Roadmap Still Thin (Maintain Hold) (NASDAQ:HALO) - Seeking Alpha
How geopolitical risks impact Halozyme Therapeutics Inc. (RV7) stockLong Setup & Weekly High Return Stock Opportunities - newser.com
How buybacks impact Halozyme Therapeutics Inc. stock valueJuly 2025 News Drivers & Reliable Breakout Stock Forecasts - newser.com
Will Halozyme Therapeutics Inc. (RV7) stock outperform global peersJuly 2025 Fed Impact & Long-Term Safe Investment Ideas - newser.com
Is it too late to sell Halozyme Therapeutics Inc.July 2025 Short Interest & Weekly Chart Analysis and Guides - newser.com
Institutional scanner results for Halozyme Therapeutics Inc.Market Growth Report & Smart Allocation Stock Tips - newser.com
Pattern recognition hints at Halozyme Therapeutics Inc. upsideM&A Rumor & Fast Entry Momentum Alerts - newser.com
What analysts say about Halozyme Therapeutics Inc stockPrice Momentum Alerts & Exceptional Return Stocks - earlytimes.in
HALO Stock Up on Q2 Earnings and Revenue Beat, Raised 2025 View - MSN
Congress Asset Management Co. Sells 297,296 Shares of Halozyme Therapeutics, Inc. $HALO - MarketBeat
Why Halozyme Therapeutics (HALO) is a Top Value Stock for the Long-Term - Yahoo Finance
Halozyme Therapeutics, Inc. $HALO Holdings Lowered by Ruffer LLP - MarketBeat
Norden Group LLC Sells 3,457 Shares of Halozyme Therapeutics, Inc. $HALO - MarketBeat
Halozyme Therapeutics Hits New 52-Week High of $79.31, Up 53% Yearly - Markets Mojo
Benchmark raises Halozyme stock price target to $90 on strong earnings - Investing.com
Halozyme Therapeutics Hits New 52-Week High of $79.46, Up 51.62% - Markets Mojo
Halozyme Therapeutics (HALO): Benchmark Raises Price Target to $90 | HALO Stock News - GuruFocus
Halozyme Therapeutics (NASDAQ:HALO) Price Target Raised to $90.00 at Benchmark - MarketBeat
Zacks Industry Outlook Highlights Halozyme Therapeutics, Akero Therapeutics, Kiniska Pharmaceuticals, ANI Pharmaceuticals and Twist BioScience - The Globe and Mail
Brokerages Set Halozyme Therapeutics, Inc. (NASDAQ:HALO) Target Price at $67.11 - MarketBeat
Halozyme Therapeutics, Inc. $HALO Stock Holdings Lowered by NorthCrest Asset Manangement LLC - MarketBeat
Insider Sell Alert: Nicole Labrosse Sells Shares of Halozyme The - GuruFocus
Shelton Wealth Management LLC Takes $843,000 Position in Halozyme Therapeutics, Inc. $HALO - MarketBeat
Insider Selling: Halozyme Therapeutics (NASDAQ:HALO) CFO Sells 2,227 Shares of Stock - MarketBeat
Livforsakringsbolaget Skandia Omsesidigt Buys 44,700 Shares of Halozyme Therapeutics, Inc. $HALO - MarketBeat
Halozyme Therapeutics and Synopsys have been highlighted as Zacks Bull and Bear of the Day - Yahoo Finance
5 Biotech Stocks Worth Adding to Your Portfolio Now - Yahoo Finance
Bull of the Day: Halozyme Therapeutics (HALO) - The Globe and Mail
Halozyme Therapeutics, Inc. $HALO Shares Purchased by Redhawk Wealth Advisors Inc. - MarketBeat
Those Who Invested in Halozyme Therapeutics (NASDAQ:HALO) Five Years Ago Are up 200% - 富途牛牛
Halozyme Therapeutics Hits New 52-Week High of $77.95, Surges 52% - Markets Mojo
Halozyme Therapeutics stock price target raised to $85 at H.C. Wainwright - Investing.com
Halozyme Therapeutics (NASDAQ:HALO) Price Target Raised to $85.00 at HC Wainwright - MarketBeat
Halozyme Therapeutics (HALO) Target Price Raised by HC Wainwrigh - GuruFocus
Halozyme Therapeutics, Inc. (HALO): Investor Outlook on a Biotech Powerhouse with a 40.8% Revenue Growth - DirectorsTalk Interviews
Swedbank AB Sells 100,100 Shares of Halozyme Therapeutics, Inc. $HALO - MarketBeat
Halozyme Therapeutics (NASDAQ:HALO) Hits New 52-Week HighWhat's Next? - MarketBeat
Livforsakringsbolaget Skandia Omsesidigt Sells 38,210 Shares of Halozyme Therapeutics, Inc. $HALO - MarketBeat
Financiere des Professionnels Fonds d investissement inc. Makes New $527,000 Investment in Halozyme Therapeutics, Inc. $HALO - MarketBeat
New Highs: Will Halozyme Therapeutics Inc. benefit from seasonality2025 Technical Patterns & Smart Money Movement Tracker - خودرو بانک
Strs Ohio Buys Shares of 30,000 Halozyme Therapeutics, Inc. $HALO - MarketBeat
Halozyme Therapeutics stock hits all-time high at 77.6 USD By Investing.com - Investing.com Nigeria
Halozyme Therapeutics stock hits all-time high at 77.6 USD - Investing.com India
FOMO Trade: What drives Halozyme Therapeutics Inc.’s stock price2025 Market WrapUp & Reliable Momentum Entry Alerts - خودرو بانک
Swedbank AB Sells 26,100 Shares of Halozyme Therapeutics, Inc. $HALO - MarketBeat
Market Catalysts: What is PSNY’s book value per share2025 Key Highlights & Advanced Technical Analysis Signals - khodrobank.com
2.36%
1.10%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):